Aleah is the Vice President of Nonclinical at Peel Therapeutics where she strategically designs, oversees, and analyzes nonclinical studies conducted across Peel’s drug development programs.
Prior to Peel, she led product development at a health-tech startup focused on matching cancer patients with relevant clinical trials.
Aleah received her Ph.D. in Genomics and Computational Biology from the University of Pennsylvania and her B.S. from Boston College. Her graduate work focused on Peto’s Paradox and the evolution of cancer suppression in large, long-lived animals, including elephants and whales. Her PhD work was the first to describe extra p53 in the elephant genome.
Aleah previously worked as a dock master at a marina in Connecticut and (unrelated) used to have a 5 ft green iguana as a pet.